Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Proteomics
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 23, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Emily Stephenson1, Suzanne Sharpton1
1Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt Health, Nashville, Tennessee, USA.
No abstract available in PubMed .